These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15570670)

  • 1. Postexposure prophylaxis for nonoccupational HIV exposure.
    Ball SC
    AIDS Read; 2004 Nov; 14(11):587-8, 593-4. PubMed ID: 15570670
    [No Abstract]   [Full Text] [Related]  

  • 2. A model for communitywide delivery of postexposure prophylaxis after potential sexual exposure to HIV.
    Roland ME
    Sex Transm Dis; 2007 May; 34(5):294-6. PubMed ID: 17308501
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV postexposure prophylaxis: Who should get it?
    Campos-Outcalt D
    J Fam Pract; 2006 Jul; 55(7):600-4. PubMed ID: 16822447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.
    Katz MH; Gerberding JL
    N Engl J Med; 1997 Apr; 336(15):1097-100. PubMed ID: 9091810
    [No Abstract]   [Full Text] [Related]  

  • 5. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004.
    Sonder GJ; van den Hoek A; Regez RM; Brinkman K; Prins JM; Mulder JW; Veenstra J; Claessen FA; Coutinho RA
    Sex Transm Dis; 2007 May; 34(5):288-93. PubMed ID: 16980918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raltegravir for postexposure prophylaxis following occupational exposure to HIV.
    Siegel MO; Kan VL; Benator DA
    AIDS; 2008 Nov; 22(18):2552-3. PubMed ID: 19005284
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonoccupational postexposure prophylaxis following sexual assault in industrialized low-HIV-prevalence countries: a review.
    Draughon JE; Sheridan DJ
    Psychol Health Med; 2012; 17(2):235-54. PubMed ID: 22372741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC Releases Updated Guidelines for Postexposure Prophylaxis After Sexual, Injection Drug, or Other Nonoccupational Exposures to HIV.
    Goldschmidt RH
    Am Fam Physician; 2016 Sep; 94(5):392-3. PubMed ID: 27583430
    [No Abstract]   [Full Text] [Related]  

  • 10. Rape of S.A. journalist brings attention to PEP.
    AIDS Alert; 1999 Aug; 14(8 Suppl):4. PubMed ID: 11366433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current world literature.
    Curr Opin HIV AIDS; 2012 Jul; 7(4):376-81. PubMed ID: 22678490
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellulose sulfate for prevention of HIV infection.
    Neurath AR
    N Engl J Med; 2008 Nov; 359(19):2066-7; author reply 2067-8. PubMed ID: 18987376
    [No Abstract]   [Full Text] [Related]  

  • 13. Most common prescribing error in postexposure prophylaxis of HIV/AIDS.
    Mahajan A; Sharma H; Bhagat A; Tandon VR; Sharma R; Sharma S
    J Assoc Physicians India; 2007 Mar; 55():246-7. PubMed ID: 17598343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Post-exposure prophylaxis following exposure to HIV: adaptation to the situation may be indicated].
    Wensing AM; Schneider MM; Schurink CA; Geerlings SE; Boucher CA
    Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1485-9. PubMed ID: 16032990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Announcement: Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV - United States, 2016.
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):458. PubMed ID: 27149423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postexposure prophylaxis after sexual exposure to HIV.
    Roland ME
    Curr Opin Infect Dis; 2007 Feb; 20(1):39-46. PubMed ID: 17197880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of guidelines on nonoccupational HIV postexposure prophylaxis for the state of Rhode Island.
    Merchant RC; Mayer KH; Browning CA
    Public Health Rep; 2004; 119(2):136-40. PubMed ID: 15192899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping HIV infection with PEP. U.S. guidelines for using established meds in an unproven way.
    Vázquez E
    Posit Aware; 2005; 16(4):15-8. PubMed ID: 16110537
    [No Abstract]   [Full Text] [Related]  

  • 19. Pre-exposure prophylaxis: increasing evidence for effectiveness but should the perspective return to test and treat?
    Desai M
    Sex Transm Infect; 2012 Oct; 88(6):475-6. PubMed ID: 23012494
    [No Abstract]   [Full Text] [Related]  

  • 20. Case studies on nonoccupational postexposure HIV prophylaxis.
    Urbina BY; Merchant RC; Mayer KH
    Med Health R I; 2003 Jun; 86(6):175-7. PubMed ID: 12973889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.